Bunkerhill Health and Cleerly Partner to Enhance Noninvasive Cardiovascular Care Bunkerhill Health, a leader in AI-driven early disease detection, has partnered with Cleerly, a pioneer in advanced cardiovascular imaging, to expand access to their technologies for detecting coronary artery disease…
FDA Accepts Gazyva sBLA for Lupus Nephritis Treatment Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Gazyva® (obinutuzumab) in the treatment of lupus…
New Data Supports DNA Vaccine Delivery via Vaxxas’ HD-MAP Technology Vaxxas, a clinical-stage biotechnology company specializing in a novel vaccination platform, announced today the publication of data validating the effectiveness of its high-density microarray patch (HD-MAP) technology for delivering nucleic…
Allurion Announces New U.S. Patents for Next-Gen Weight Loss Device Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, announced today that it has received two Issue Notifications from the U.S. Patent and Trademark Office (USPTO) for its…
GeneDx Expands Exome and Genome Testing to Include Cerebral Palsy GeneDx (Nasdaq: WGS), a leader in providing genomic insights to enhance health outcomes, announced today the expansion of its genetic testing services to include cerebral palsy (CP). In celebration of…
GE HealthCare Unveils Genesis Portfolio to Accelerate Digital Innovation Adoption GE HealthCare (Nasdaq: GEHC) has announced the launch of its new Genesis solutions, a comprehensive portfolio of cloud-based enterprise imaging software-as-a-service (SaaS) offerings. When commercially released, Genesis will feature four…
Cadrenal Therapeutics Partners with Abbott for Tecarfarin Pivotal Study in HeartMate 3™ LVAD Patients Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company specializing in cardiovascular therapeutics, has announced the signing of a Collaboration Agreement with Abbott (NYSE: ABT). This partnership…
Sensus Healthcare Study Shows SRT-100® Prevents Keloid Recurrence at Taiwan’s Tri-Service Military Hospital Sensus Healthcare, Inc. (Nasdaq: SRTS), a leading medical device company focused on providing effective, non-invasive, and cost-efficient treatments for both oncological and non-oncological skin conditions, has announced…
InductiveHealth Partners with Origami Risk to Modernize Public Health Surveillance InductiveHealth, a leading provider of disease and syndromic surveillance systems and services, has announced an exclusive partnership with Origami Risk, a global leader in risk, safety, and insurance Software as…
Epredia Gets FDA 510(K) Clearance for E1000 Dx™ Digital Pathology Solution Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation, announced today that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance…
Ntracts Acquires Compliatric to Enhance Healthcare Compliance Support Ntracts, a leader in contract lifecycle management (CLM) solutions for the healthcare industry, announced today the acquisition of Compliatric, a provider of regulatory, accreditation, and compliance management technology for healthcare organizations. This…
FDA Grants Orphan and Pediatric Designations to NEU-001 for Hirschsprung’s Disease Neurenati Therapeutics Inc., a biotechnology company dedicated to pediatric rare diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and…